Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Szabolcsi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Dermatologische Monatschrift|April 1, 1973
[Pathogenesis of candidiasis]E Balogh, M Szabolcsi
JAMA|January 26, 1979
Middle-altitude edema and aldosteroneW Wiltner, L M Szabolcsi
Acta Medica Academiae Scientiarum Hungaricae|January 1, 1979
Levamisole in the treatment of Hodgkin's diseaseE Berényi, M Kávai, M Szabolcsi, et al.
Mykosen|August 1, 1971
Experimental investigation of immunreactivity against Candida albicans. 1. Reaction of rabbits immunized with Candida albicans and challenged with living Candida albicansE Balogh, G Kakuk, K Halmy, et al.
Zeitschrift Fur Hautkrankheiten|June 15, 1981
[T & B-lymphocytes and immunoglobulins of the serum in drug eruptions of immediate type (author's transl)]C Mészáros, M Debreczeni, M Szabolcsi, et al.
Mykosen|February 1, 1972
Experimental investigation of immunreactivity against Candida albicans. 2. The effect of azathioprin (Imuran) on immunreactivity against Candida albicansG Kakuk, E Balogh, M Szabolcsi, et al.
International Journal of Dermatology|September 1, 1989
Poikiloderma atrophicans vasculare in patient with Sjögren syndromeM Zeher, M Szabolcsi, G Kelényi, et al.
Dermatologische Monatschrift|February 1, 1976
[Immunological aspects of the susceptibility for mycotic infections]E Balogh, G Szegedi, L Karmazsin, et al.
The New England Journal of Medicine|April 21, 1977
Use of levamisole in Hodgkin's diseaseE Berényi, I Sonkoly, M Kávai, et al.
Mykosen|May 1, 1976
[Therapeutic experiences with transfer factor in chronic cutaneous cadidiasis treatment]G Szegedi, E Balogh, L Karmazsin, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Dermatologische Monatschrift|April 1, 1973
[Pathogenesis of candidiasis]E Balogh, M Szabolcsi
JAMA|January 26, 1979
Middle-altitude edema and aldosteroneW Wiltner, L M Szabolcsi
Acta Medica Academiae Scientiarum Hungaricae|January 1, 1979
Levamisole in the treatment of Hodgkin's diseaseE Berényi, M Kávai, M Szabolcsi, et al.
Mykosen|August 1, 1971
Experimental investigation of immunreactivity against Candida albicans. 1. Reaction of rabbits immunized with Candida albicans and challenged with living Candida albicansE Balogh, G Kakuk, K Halmy, et al.
Zeitschrift Fur Hautkrankheiten|June 15, 1981
[T & B-lymphocytes and immunoglobulins of the serum in drug eruptions of immediate type (author's transl)]C Mészáros, M Debreczeni, M Szabolcsi, et al.
Mykosen|February 1, 1972
Experimental investigation of immunreactivity against Candida albicans. 2. The effect of azathioprin (Imuran) on immunreactivity against Candida albicansG Kakuk, E Balogh, M Szabolcsi, et al.
International Journal of Dermatology|September 1, 1989
Poikiloderma atrophicans vasculare in patient with Sjögren syndromeM Zeher, M Szabolcsi, G Kelényi, et al.
Dermatologische Monatschrift|February 1, 1976
[Immunological aspects of the susceptibility for mycotic infections]E Balogh, G Szegedi, L Karmazsin, et al.
The New England Journal of Medicine|April 21, 1977
Use of levamisole in Hodgkin's diseaseE Berényi, I Sonkoly, M Kávai, et al.
Mykosen|May 1, 1976
[Therapeutic experiences with transfer factor in chronic cutaneous cadidiasis treatment]G Szegedi, E Balogh, L Karmazsin, et al.
Pageof 2